Moreover, numerous EV-circRNAs increase the levels of immune checkpoint proteins, including PD-1/PD-L1, in both tumor and immune cells via diverse cytokine-mediated signaling pathways, thereby modulating the capacity of immune cells to combat tumors. This evidence concerns the gene PDCD1 and neoplasm.